Show simple item record

dc.contributor.authorOlivencia, Miguel A.
dc.contributor.authorMartínez‐Casales, Marta
dc.contributor.authorPeraza Pérez, Diego Alberto
dc.contributor.authorGarcía‐Redondo, Ana B.
dc.contributor.authorMondéjar‐Parreño, Gema
dc.contributor.authorHernanz, Raquel
dc.contributor.authorSalaices, Mercedes
dc.contributor.authorCogolludo, Angel
dc.contributor.authorPennington, Michael W.
dc.contributor.authorValenzuela, Carmen
dc.contributor.authorBriones, Ana M.
dc.date.accessioned2024-02-08T17:05:46Z
dc.date.available2024-02-08T17:05:46Z
dc.date.issued2021
dc.identifier.citationBr J Pharmacol . 2021 Apr;178(8):1836-1854. doi: 10.1111/bph.15407. Epub 2021 Mar 1.es
dc.identifier.issn0007-1188es
dc.identifier.urihttps://uvadoc.uva.es/handle/10324/66031
dc.description.abstractBackground and purpose: KV 1.3 channels are expressed in vascular smooth muscle cells (VSMCs), where they contribute to proliferation rather than contraction and participate in vascular remodelling. KV 1.3 channels are also expressed in macrophages, where they assemble with KV 1.5 channels (KV 1.3/KV 1.5), whose activation generates a KV current. In macrophages, the KV 1.3/KV 1.5 ratio is increased by classical activation (M1). Whether these channels are involved in angiotensin II (AngII)-induced vascular remodelling, and whether they can modulate the macrophage phenotype in hypertension, remains unknown. We characterized the role of KV 1.3 channels in vascular damage in hypertension. Experimental approach: We used AngII-infused mice treated with two selective KV 1.3 channel inhibitors (HsTX[R14A] and [EWSS]ShK). Vascular function and structure were measured using wire and pressure myography, respectively. VSMC and macrophage electrophysiology were studied using the patch-clamp technique; gene expression was analysed using RT-PCR. Key results: AngII increased KV 1.3 channel expression in mice aorta and peritoneal macrophages which was abolished by HsTX[R14A] treatment. KV 1.3 inhibition did not prevent hypertension, vascular remodelling, or stiffness but corrected AngII-induced macrophage infiltration and endothelial dysfunction in the small mesenteric arteries and/or aorta, via a mechanism independent of electrophysiological changes in VSMCs. AngII modified the electrophysiological properties of peritoneal macrophages, indicating an M1-like activated state, with enhanced expression of proinflammatory cytokines that induced endothelial dysfunction. These effects were prevented by KV 1.3 blockade. Conclusions and implications: We unravelled a new role for KV 1.3 channels in the macrophage-dependent endothelial dysfunction induced by AngII in mice which might be due to modulation of macrophage phenotype.es
dc.format.mimetypeapplication/pdfes
dc.language.isospaes
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.titleKV1.3 channels are novel determinants of macrophage‐dependent endothelial dysfunction in angiotensin II‐induced hypertension in micees
dc.typeinfo:eu-repo/semantics/articlees
dc.identifier.doi10.1111/bph.15407es
dc.identifier.publicationfirstpage1836es
dc.identifier.publicationissue8es
dc.identifier.publicationlastpage1854es
dc.identifier.publicationtitleBritish Journal of Pharmacologyes
dc.identifier.publicationvolume178es
dc.peerreviewedSIes
dc.identifier.essn1476-5381es
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record